| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLETS, USP 40-8843 Revised – January 2008 Rx Only | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin safely and effectively. See full prescribing information for simvastatin. Simvastatin Tablets, USP for Oral use Initial U.S. Approval: 1991 | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP for oral use Initial U.S. Approval: 1991 | 4 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP for oral use Initial U.S. Approval: 1991 | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | 392476e1-49fd-4014-bb52-b31937077c33 | 3 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP for oral use Initial U.S. Approval: 1991 | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP for oral use Initial U.S. Approval: 1991 | 11 | |
| butylated hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | Lovastatin Tablet USP | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | AMCINONIDE OINTMENT USP, 0.1% | 4 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin tablets, USP safely and effectively. See full prescribing information for simvastatin tablets, USP. Simvastatin tablets, USP Initial U.S. Approval: 1991 | 10 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | CLARAVIS™ (isotretinoin capsules USP) | 4 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Meijer Elements Maximum Strength For Diaper Rash Paste | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | 8cb751f8-9a7d-4f2b-94b8-7f40ab2c23a6 | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Cottontails Maximum Strength Original Diaper Rash Paste | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin safely and effectively. See full prescribing information for simvastatin tablets, USP. Simvastatin Tablets, USP Initial U.S. Approval: 1991 | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Little Ones Maximum Strength Original Diaper Paste | 1 | |
| Butylated Hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | 0ef40acf-0c28-42a9-a0a8-45c13abb40f4 | 13 | |
| Butylated Hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | dad188ee-d2b6-4529-a42b-2cf7746dcd18 | 13 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | CALCITRIOL CAPSULES and ORAL SOLUTION Rx only | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Drug Facts | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | 019bf296-8fe3-473e-adea-26463820b630 | 7 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | 3259fef2-b2e2-40aa-b383-601d65e982c4 | 4 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | dfa588ae-1f3a-4a8f-be0f-027b0938fb11 | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin tablets USP safely and effectively. See full prescribing information for simvastatin tablets USP. SIMVASTATIN tablets USP for oral use Initial U.S. Approval: 1991 | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | 98807784-7c1f-4ec5-bf1e-d5748f62eced | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | fe994e8c-147d-44ae-b437-930db3f42bd3 | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Myorisan TM (isotretinoin capsules, USP) 10 mg, 20 mg, 40 mg | 2 | |
| butylated hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLETS USP | 5 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Miconazole Nitrate Antifungal Cream | 2 | |
| butylated hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use VYTORIN safely and effectively. See full prescribing information for VYTORIN. VYTORIN® (ezetimibe/simvastatin) Tablets Initial U.S. Approval: 2004 | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Flunisolide Nasal Solution USP, 0.025% | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin safely and effectively. See full prescribing information for simvastatin. SIMVASTATIN TABLETS, USP Initial U.S. Approval: 1991 | 7 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. SIMVASTATIN TABLETS USP Initial U.S. Approval: 1991 | 3 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Simvastatin Tablets Tablet, Film Coated Rx Only. These highlights do not include all the information needed to use S imvastatin safely and effectively. See full prescribing information for S imvastatin. Simvastatin (Simvastatin) tablets for oral administration Initial U.S. Approval: 1991 | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | 0018861f-1b9b-431b-84ee-9d34aab615c3 | 5 | |
| Butylated Hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | Pediatric Acephen TM, Acetaminophen Suppositories, 120 mg | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets, USP Initial U.S. Approval: 1991 | 6 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. SIMVASTATIN TABLETS USP Initial U.S. Approval: 1991 | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | 40840f67-7066-4bb6-85c1-73eb2618cd26 | 4 | |
| butylated hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | Ketoconazole Cream, 2% | 1 | |
| butylated hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | Lovastatin Tablet USP | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Drug Facts | 4 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Drug Facts | 4 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | TERCONAZOLE VAGINAL CREAM 0.4% 7-Day Regimen TERCONAZOLE VAGINAL CREAM 0.4% 3-Day Regimen | 3 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP Initial U.S. Approval: 1991 | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. SIMVASTATIN TABLETS USP Initial U.S. Approval: 1991 | 8 | |
| butylated hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | Lovastatin Tablet USP | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | CALCITRIOL CAPSULES and ORAL SOLUTION Rx only | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | DRUG FACTS | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | drug facts | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Hydrocortisone Acetate | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | 71139e30-10c8-4474-b7a3-b575c3fd32f9 | 4 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Drug Facts | 3 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use simvastatin safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets, USP Initial U.S. Approval: 1991 | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Acetaminophen, Dextromethorpan HBr & Doxylamine Succinate capsule | 3 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Acetaminophen, Dextromethorpan HBr & Phenylephrine HCL capsule | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | b8fb4dcd-2531-40d3-bbfb-ccdc8ce327c4 | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | These highlights do not include all the information needed to use SIMCOR ® safely and effectively. See full prescribing information for SIMCOR. SIMCOR (simvastatin/niacin extended-release) tablet, film coated, extended release for oral use. Initial U.S. Approval: 2008 | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | drug facts | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | ENJUVIA® (synthetic conjugated estrogens, B) Tablets | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | Carton and jar labelling | 3 | |
| Butylated Hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | Drug Facts | 1 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | TEMPRA (ACETAMINOPHEN) SYRUP [BRISTOL-MYERS SQUIBB DE MEXICO, S. DE R.L. DE C.V.] | 201509 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET [MICRO LABS LIMITED] | 90388 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3252 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | ZOCOR (SIMVASTATIN) TABLET, FILM COATED [LAKE ERIE MEDICAL SURGICAL & SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3061 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMCOR (NIACIN AND SIMVASTATIN) TABLET, FILM COATED, EXTENDED RELEASE [ABBVIE INC.] | 1449 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLET [BRYANT RANCH PREPACK] | 1001 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | DESMOPRESSIN ACETATE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLET [BRYANT RANCH PREPACK] | 1000 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1000 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | VYTORIN (EZETIMIBE SIMVASTIN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 400 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | VYTORIN (EZETIMIBE/SIMVASTIN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 369 | |
| butylated hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | VYTORIN (EZETIMIBE AND SIMVASTATIN) TABLET [MERCK SHARP & DOHME CORP.] | 43 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN (SIMVASTATIN) TABLET [REMEDYREPACK INC. ] | 41 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SEVERE COLD AND FLU (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL) SOLUTION [WALGREEN COMPANY] | 32 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.] | 32 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | ZOCOR (SIMVASTATIN) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.] | 30 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 26 | |
| butylated hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | VYTORIN (EZETIMIBE AND SIMVASTATIN) TABLET [PD-RX PHARMACEUTICALS, INC.] | 24 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | ALTOPREV (LOVASTATIN) TABLET, EXTENDED RELEASE [SHIONOGI INC.] | 23 | |
| butylated hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | VYTORIN (EZETIMIBE AND SIMVASTATIN) TABLET [PD-RX PHARMACEUTICALS, INC.] | 22 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLET [EON LABS, INC.] | 21 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | MONTELUKAST SODIUM TABLET, CHEWABLE MONTELUKAST SODIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.] | 21 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLET [INTERNATIONAL LABS, INC.] | 20 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 20 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 17 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | MEVACOR (LOVASTATIN) TABLET [MERCK SHARP & DOHME CORP.] | 16 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] | 15 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | M.V.I. ADULT (RETINOL, ERGOCALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PHYTONADIONE, ASCORBIC ACID, NIACINAMIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, BIOTIN, FOLIC ACID, AND CYANOCOBALAMIN) KIT [HOSPIRA WORLDWIDE, INC.] | 14 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | M.V.I.-12 (RETINOL, ERGOCALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, NIACINAMIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, BIOTIN, FOLIC ACID, AND CYANOCOBALAMIN) KIT [HOSPIRA WORLDWIDE, INC.] | 13 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [ACCORD HEALTHCARE, INC.] | 13 | |
| butylated hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | LORATADINE SOLUTION [SILARX PHARMACEUTICALS, INC] | 12 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLET [ACTAVIS INC.] | 12 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLET [TEVA PHARMACEUTICALS USA INC] | 12 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 12 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | M.V.I. ADULT (RETINOL, ERGOCALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PHYTONADIONE, ASCORBIC ACID, NIACINAMIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, BIOTIN, FOLIC ACID, AND CYANOCOBALAMIN) KIT [HOSPIRA WORLDWIDE, INC.] | 11 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [BLU PHARMCEUTICALS LLC] | 11 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | ZENATANE (ISOTRETINOIN) CAPSULE, GELATIN COATED [DR. REDDY'S LABORATORIES LIMITED] | 11 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 10 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 10 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | STROMECTOL (IVERMECTIN) TABLET [MERCK SHARP & DOHME CORP.] | 10 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | CONAZOL (MICONAZOLE NITRATE) CREAM [MARCASUSA LLC] | 9 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | HECTOROL (DOXERCALCIFEROL) CAPSULE, LIQUID FILLED HECTOROL (DOXERCALCIFEROL) CAPSULE, LIQUID FILLED [GENZYME CORPORATION] | 9 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LEVOTHYROXINE SODIUM TABLET [CARDINAL HEALTH] | 9 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | MYORISAN (ISOTRETINOIN) CAPSULE, LIQUID FILLED [VERSAPHARM INCORPORATED] | 9 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SENTINEL SPECTRUM (MILBEMYCIN OXIME, LUFENURON AND PRAZIQUANTEL) TABLET, CHEWABLE [NOVARTIS ANIMAL HEALTH US, INC.] | 9 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [DR. REDDY'S LABORATORIES LIMITED] | 9 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [NORTHSTAR RX LLC] | 9 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | TERAZOL 7 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) SUPPOSITORY [ORTHO-MCNEIL-JANSSEN PHARMACEUTICAL] | 9 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | CALCITRIOL CAPSULE [ROXANE LABORATORIES, INC.] | 8 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | CALCITRIOL SOLUTION [ROXANE LABORATORIES, INC] | 8 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLET [MYLAN PHARMACEUTICALS INC.] | 8 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | LOVASTATIN TABLET [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 8 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | SIMVASTATIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | ALAVERT ALLERGY (LORATADINE) TABLET, ORALLY DISINTEGRATING [PFIZER CONSUMER HEALTHCARE] | 7 | |